| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/24/2012 | WO2012068109A2 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 05/24/2012 | WO2012068041A1 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS |
| 05/24/2012 | WO2012068038A2 Caffeic acid derivatives and their use in improving neuronal cell viability |
| 05/24/2012 | WO2012067970A2 Transcriptional repression leading to parkinson's disease |
| 05/24/2012 | WO2012067863A1 Heterocyclic compounds as imaging probes of tau pathology |
| 05/24/2012 | WO2012067824A1 Potassium channel modulators |
| 05/24/2012 | WO2012067305A1 COMPOSITIONS FOR REDUCING BETA-AMYLOID-INDUCED NEUROTOXICITY COMPRISING β-SECRETASE INHIBITOR |
| 05/24/2012 | WO2012067111A1 PKC-ε ACTIVATOR |
| 05/24/2012 | WO2012066994A1 Pharmaceutical formulation having neuroprotective activity |
| 05/24/2012 | WO2012066549A1 Dipeptide analogs for treating conditions associated with amyloid fibril formation |
| 05/24/2012 | WO2012066538A1 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same |
| 05/24/2012 | WO2012066330A1 Compounds useful as a2a receptor inhibitors |
| 05/24/2012 | WO2012066319A1 Apomorphine by pulmonary inhalation, oprionally in combination with l-dopa or a dopamine agonist for use in the treatment of parkinson |
| 05/24/2012 | WO2012066002A1 Flavagline derivatives as neuroprotective agents |
| 05/24/2012 | WO2012065612A1 Imidazole derivatives as pde10a enzyme inhibitors |
| 05/24/2012 | WO2012065527A1 Compouds and uses as l-type calcium channel blocker and/or acetylcholinesterase inhibitor thereof |
| 05/24/2012 | WO2012065362A1 Myomegalin variant 8 and uses thereof |
| 05/24/2012 | WO2012065248A1 Method for increasing neprilysin expression and activity |
| 05/24/2012 | WO2012028963A3 Compositions including a sodium channel blocker (lamotrigine) and a b vitamin molecule (folate) for use in treating a psychological, a neurological, a neurodegenerative disorder, and a disorder involving pain |
| 05/24/2012 | WO2012021800A3 Caspase inhibitors as therapeutics for neural and organ injury and imaging |
| 05/24/2012 | WO2012020991A3 Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients |
| 05/24/2012 | WO2011159903A3 Asenapine maleate |
| 05/24/2012 | WO2011150281A4 A compositon for neurological or autoimmune diseases |
| 05/24/2012 | US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics |
| 05/24/2012 | US20120129945 Inhibitors of cognitive decline |
| 05/24/2012 | US20120129940 Methods of treating autism |
| 05/24/2012 | US20120129939 Polyamine inhibitors for the treatment and prevention of parkinson's disease |
| 05/24/2012 | US20120129934 Methods for the treatment of senile dementia of the alzheimer's type |
| 05/24/2012 | US20120129932 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 05/24/2012 | US20120129931 Caffeic acid derivatives and their use in improving neuronal cell viability |
| 05/24/2012 | US20120129930 Ketone compounds and compositions for cholesterol management and related uses |
| 05/24/2012 | US20120129926 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| 05/24/2012 | US20120129912 RNA Targeting in Alpha-Synucleinopathies |
| 05/24/2012 | US20120129909 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same |
| 05/24/2012 | US20120129906 Modulators of s1p receptors |
| 05/24/2012 | US20120129902 4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS |
| 05/24/2012 | US20120129897 Bis heteroaryl inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129892 Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl)pyridine and their therapeutical uses |
| 05/24/2012 | US20120129889 Non-competitive NMDA receptor antagonists |
| 05/24/2012 | US20120129886 Metalloenzyme inhibitor compounds |
| 05/24/2012 | US20120129885 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof |
| 05/24/2012 | US20120129883 Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation ofthe serotonin 5-ht6 receptor |
| 05/24/2012 | US20120129878 Tablet |
| 05/24/2012 | US20120129877 Use of quinazoline derivatives for neurodegenerative diseases |
| 05/24/2012 | US20120129873 Inhibitors of bruton's tyrosine kinase |
| 05/24/2012 | US20120129872 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129870 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 05/24/2012 | US20120129868 Poly (adp-ribose) polymerase (parp) inhibitors |
| 05/24/2012 | US20120129866 Methods for preventing or treating metabolic diseases, inflammatory diseases, autoimmune diseases, allergic diseases, central nervous system diseases, cardiovascular diseases, homeostasis-related diseases or glaucoma |
| 05/24/2012 | US20120129864 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same |
| 05/24/2012 | US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation |
| 05/24/2012 | US20120129849 Deuterated serine-threonine protein kinase modulators |
| 05/24/2012 | US20120129846 Gamma secretase modulators |
| 05/24/2012 | US20120129843 Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129842 Bisthiazole inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129839 Methods of treating disorders associated with protein polymerization |
| 05/24/2012 | US20120129836 Imidazole derivatives as PDE10A enzyme inhibitors |
| 05/24/2012 | US20120129835 Schizophrenia methods and compositions |
| 05/24/2012 | US20120129834 Serotonin receptor antagonists for use in the treatment of huntington's disease |
| 05/24/2012 | US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof |
| 05/24/2012 | US20120129829 Novel indole modulators of s1p receptors |
| 05/24/2012 | US20120129828 S1p1 receptor agonists and use thereof |
| 05/24/2012 | US20120129826 Method of Treating Depression |
| 05/24/2012 | US20120129822 Composition containing diosgenin and use thereof to improve at least one of cognitive deficits associated with menopausal syndrome |
| 05/24/2012 | US20120129819 Gel compositions for administration of pharmaceutically active compounds |
| 05/24/2012 | US20120129816 Aryl sulfonamide amine compounds and their use as 5-ht6 ligands |
| 05/24/2012 | US20120129814 Novel phosphonic acids as s1p receptor modulators |
| 05/24/2012 | US20120129813 Novel compounds as receptor modulators with therapeutic utility |
| 05/24/2012 | US20120129811 Tricyclic inhibitors of pro-matrix metalloproteinase activation |
| 05/24/2012 | US20120129803 Composition containing chitooligosaccharide for recovering from fatigue |
| 05/24/2012 | US20120129790 Methods of use of epsilon inhibitor compounds for the attenuation of pain |
| 05/24/2012 | US20120129784 Oligopeptides And Cosmetic Compositions Containing The Oligopeptides |
| 05/24/2012 | US20120129783 Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
| 05/24/2012 | US20120129782 Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders |
| 05/24/2012 | US20120129781 Composition comprising alpha-lipoic acid and carnosine for treating the phantom limb syndrome |
| 05/24/2012 | US20120129780 Lactoferrin and brain health and protection in adults |
| 05/24/2012 | US20120129776 Bioactive peptides and method of using same |
| 05/24/2012 | US20120129773 Methods of treating autism and autism spectrum disorders |
| 05/24/2012 | US20120129771 Peptides and related molecules that modulate nerve growth factor activity |
| 05/24/2012 | US20120128798 Method of Treating Neurological Conditions with Extract of Nerium Species or Thevetia Species |
| 05/24/2012 | US20120128789 Use of xenon for treating hypersensitivity to pain |
| 05/24/2012 | US20120128778 Compositions and methods for once-daily administration of a trilayer osmotic tablet |
| 05/24/2012 | US20120128772 Controlled release pharmaceutical compositions of milnacipran |
| 05/24/2012 | US20120128771 Timed, pulsatile release systems |
| 05/24/2012 | US20120128768 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 05/24/2012 | US20120128753 Meditowel pre-packaged medicated muscle and joint pain relief wipe |
| 05/24/2012 | US20120128741 Modified hyaluronic acid polymer compositions and related methods |
| 05/24/2012 | US20120128735 Methods of treatment using a gastric retained gabapentin dosage |
| 05/24/2012 | US20120128730 Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron |
| 05/24/2012 | US20120128711 Anti-inflammatory approach to prevention and suppression of post-traumatic stress disorder, traumatic brain injury, depression and associated disease states |
| 05/24/2012 | US20120128707 Streptococcus pneumoniae proteins and nucleic acids |
| 05/24/2012 | US20120128700 Constructs for delivery of therapeutic agents to neuronal cells |
| 05/24/2012 | US20120128699 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 05/24/2012 | US20120128695 Teneurin c-terminal associated peptides (tcap) and methods and uses thereof |
| 05/24/2012 | US20120128694 Therapeutic agents for alzheimer's disease and cancer |
| 05/24/2012 | US20120128689 Anti-il-23 immunoglobulins |
| 05/24/2012 | US20120128686 Thienopyrimidines for pharmaceutical compositions |
| 05/24/2012 | US20120128683 Autism treatment |
| 05/24/2012 | US20120128679 Human Antibodies to the Glucagon Receptor |
| 05/24/2012 | US20120128666 Methods of increasing neuronal differentiation using antibodies to lysophosphatidic acid |